Annual Shareholders Equity
$91.29 M
-$161.07 M-63.83%
31 December 2023
Summary:
Dyne Therapeutics annual stockholders equity is currently $91.29 million, with the most recent change of -$161.07 million (-63.83%) on 31 December 2023. During the last 3 years, it has fallen by -$251.07 million (-73.34%). DYN annual shareholders equity is now -75.21% below its all-time high of $368.20 million, reached on 31 December 2021.DYN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$705.54 M
-$69.65 M-8.99%
30 September 2024
Summary:
Dyne Therapeutics quarterly stockholders equity is currently $705.54 million, with the most recent change of -$69.65 million (-8.99%) on 30 September 2024. Over the past year, it has increased by +$553.50 million (+364.06%). DYN quarterly shareholders equity is now -8.99% below its all-time high of $775.19 million, reached on 30 June 2024.DYN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.8% | +364.1% |
| 3 y3 years | -73.3% | +70.4% |
| 5 y5 years | +1971.1% | - |
DYN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.2% | at low | -9.0% | +672.8% |
| 5 y | 5 years | -75.2% | +1971.1% | -9.0% | +4926.6% |
| alltime | all time | -75.2% | +1971.1% | -9.0% | +4926.6% |
Dyne Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $705.54 M(-9.0%) |
| June 2024 | - | $775.19 M(+62.2%) |
| Mar 2024 | - | $478.06 M(+423.7%) |
| Dec 2023 | $91.29 M(-63.8%) | $91.29 M(-40.0%) |
| Sept 2023 | - | $152.04 M(-26.5%) |
| June 2023 | - | $206.88 M(-14.5%) |
| Mar 2023 | - | $241.94 M(-4.1%) |
| Dec 2022 | $252.36 M | $252.36 M(+1.0%) |
| Sept 2022 | - | $249.74 M(-13.0%) |
| June 2022 | - | $287.06 M(-14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $336.46 M(-8.6%) |
| Dec 2021 | $368.20 M(+7.5%) | $368.20 M(-11.1%) |
| Sept 2021 | - | $414.12 M(-8.5%) |
| June 2021 | - | $452.60 M(-5.4%) |
| Mar 2021 | - | $478.26 M(+39.7%) |
| Dec 2020 | $342.37 M(+2339.2%) | $342.37 M(-6.7%) |
| Sept 2020 | - | $366.85 M(+176.9%) |
| June 2020 | - | $132.48 M(+843.9%) |
| Dec 2019 | $14.04 M(-387.7%) | $14.04 M |
| Dec 2018 | -$4.88 M | - |
FAQ
- What is Dyne Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Dyne Therapeutics?
- What is Dyne Therapeutics annual shareholders equity year-on-year change?
- What is Dyne Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly shareholders equity year-on-year change?
What is Dyne Therapeutics annual stockholders equity?
The current annual shareholders equity of DYN is $91.29 M
What is the all time high annual shareholders equity for Dyne Therapeutics?
Dyne Therapeutics all-time high annual stockholders equity is $368.20 M
What is Dyne Therapeutics annual shareholders equity year-on-year change?
Over the past year, DYN annual stockholders equity has changed by -$161.07 M (-63.83%)
What is Dyne Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DYN is $705.54 M
What is the all time high quarterly shareholders equity for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly stockholders equity is $775.19 M
What is Dyne Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DYN quarterly stockholders equity has changed by +$553.50 M (+364.06%)